Individualizing cardiac care, the field of Cardiac Personalized Medicine is at the forefront of transforming cardiovascular treatment paradigms. This innovative approach tailors medical interventions for heart health based on an individual's distinct genetic composition, lifestyle, and specific cardiac conditions. By embracing cutting-edge technologies, including genetics, biomarkers, and diagnostics, Cardiac Personalized Medicine aims to redefine how we approach prevention, diagnosis, and treatment of cardiovascular diseases. The personalized aspect extends beyond genetics, considering lifestyle factors and patient-specific cardiac nuances. The potential impact of Cardiac Personalized Medicine is profound, as it strives to not only enhance treatment precision but also to create a more patient-centered cardiovascular healthcare landscape. As advancements in research and technology persist, the evolution of personalized medicine promises to be a key driver in optimizing cardiac care outcomes.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt